The clinical research of refractory atelectasis treaed with high dosage ambroxol

VernacularTitle:大剂量氨溴索治疗顽固性肺不张的临床研究
Author: Ying WANG
Publication Type:Journal Article
Keywords: Atelectasis; Ambroxol
From: Chinese Journal of Primary Medicine and Pharmacy 2014;21(12):1793-1794
CountryChina
Language:Chinese
Abstract: Objective To explore the clinical effect of refractory atelectasis treated with high dose ambroxol.Methods 112 patients with refractory atelectasis were selected as research subjects.All the patients were divided into two groups with each group 56 patients according to admission order.The control group received symptom treatment,physics treatment and routine dosage ambroxol,while the observation group received high dose ambroxol.The clinical effect and safe between two groups were compared.Results The excellence rate and total effective rate of the observation group were 71.43％ (40/56) and 100.00％ (56/56),respectively,which were higher than 51.79％ (29/56) and 83.93％ (47/56) of the control group (x2 =4.57,9.79,all P ＜ 0.05).There were no statistical difference on the total adverse effect incidence rates between the two groups(x2 =0.15,P ＞0.05).No other sever adverse effects happened in both groups.Conclusion Compared with routine dosage ambroxol,the clinical effect of refractory atelectasis treated with high dose ambroxol was better.The treatment was also safe.It was worth generalizing on the treatment of refractory atelectasis.